证券记录 · 已归档季度
ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
19被追踪持有人
+1Δ持有人
54.43M持有股份
$8.86B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 +5.6% ·
净新建仓位 +5.3%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +5 | 282.32M | $20.34B | +9 | −3 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | — | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | — |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | — | — |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | — |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | — | 38.28M | $6.63B | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 19.84M | — | $3.23B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 10.62M | +1.8% | $1.73B | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 10.62M | +1.8% | $1.73B | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 6.56M | -1.8% | $1.07B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 5.06M | +1.9% | $824.32M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 1.84M | -55.5% | $299.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 1.84M | -55.5% | $299.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.09M | 新增 | $177.68M | 0.2% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.09M | 新增 | $177.68M | 0.2% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 788.43K | -3.0% | $128.46M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 788.43K | -3.0% | $128.46M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 788.43K | -3.0% | $128.46M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 18 | Millennium Management ✦ | 425.42K | +277.6% | $69.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 288.69K | +324.5% | $47.04M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 288.69K | +324.5% | $47.04M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 26 | Arrowstreet Capital ✦ | 267.68K | +1269.3% | $43.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 138.24K | +632.7% | $22.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 135.25K | -37.8% | $22.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Bridgewater Associates ✦ | 98.39K | +90.0% | $16.03M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 13.38K | -2.4% | $2.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 7.97K | +100.8% | $1.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Fisher Asset Management ✦ | 2.85K | +46.2% | $464,308 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | Dodge & Cox ✦ | 1.70K | 0.0% | $276,981 | 0.0% | Held | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $177.68M | 0.2% |
| Citadel Advisors | $177.68M | 0.2% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,596 持有人, 404.54M 股份, $46.32B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Jul 30
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据